Vaniqa 11.5% Cream is a prescription-only topical treatment designed to reduce the growth of excessive facial hair (hirsutism) in women. Its active ingredient, eflornithine, inhibits an enzyme called ornithine decarboxylase, which is involved in hair follicle growth. By interfering with this enzyme, Vaniqa slows the rate of hair production in the applied area.
Unlike depilatory products, which remove hair above the surface, Vaniqa works at the follicular level to reduce regrowth over time. It does not remove existing hair, so it is commonly used in conjunction with physical hair removal methods.
Why Choose Vaniqa 11.5% Cream
Vaniqa provides a medically approved, non-invasive way to manage unwanted facial hair. It is specifically formulated for women and is often recommended for those experiencing hirsutism due to hormonal imbalances or conditions such as polycystic ovary syndrome (PCOS). It is particularly beneficial for women who prefer a long-term solution rather than frequent hair removal sessions.
Benefits of Vaniqa include:
-
Prescription-strength treatment for facial hirsutism
-
Targets hair growth beneath the skin
-
Suitable for all skin types
-
Can be used alongside physical hair removal methods
-
Discreet, odourless, and easily absorbed cream
With regular use, users typically report smoother skin, reduced hair thickness, and fewer visible hairs over time.
Important Note
Vaniqa is for external use only on the face and under the chin. It should not be applied to broken skin, mucous membranes, or areas affected by acne or inflammation. If no improvement is seen after four months of treatment, consult your doctor. Hair growth may gradually return if treatment is discontinued. This medicine is not intended for use in men or children.
